-+ 0.00%
-+ 0.00%
-+ 0.00%
Artiva Biotherapeutics CEO Fred Aslan disposes of 23,429 common shares worth $255,725
Share
Listen to the news
Artiva Biotherapeutics CEO Fred Aslan disposes of 23,429 common shares worth $255,725
  • Artiva Biotherapeutics CEO Fred Aslan sold 23,429 shares of common stock on Sept. 8, 2026.
  • Weighted average sale price USD 10.92 per share.
  • Directly held stake fell to 1,449,765 shares following the sale.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-386431), on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending